Peptide Research Collection Library
Explore the compound
Quick Facts
Mechanism of Action
5-Amino-1MQ is a small-molecule NNMT inhibitor used in metabolic research. Its mechanism is associated with NAD+ metabolism, adipocyte signaling, and energy-expenditure pathways.
Mechanism of Action: is associated with NAD+ metabolism, adipocyte signaling, and energy-expenditure pathways.
- Supports mitochondrial energy-production and metabolic-signaling research pathways [1].
- Commonly discussed for endurance, cellular energy, and metabolic-flexibility support based on mechanistic literature [1].
- Associated with oxidative-stress and inflammation-related endpoints in biomedical research [1].
- Official NIH-indexed databases provide the research trail for cellular metabolism and exercise-performance mechanisms [1][3].
Research Applications & Context
Community-reported protocol schedules.
Research Dosage Information
Reported research quantities and their source context. These are not recommendations, and source status varies.
Scroll the table horizontally to read every column. Select a row to inspect it in the calculator.
Community report 1 · Days 1-2 (Tolerance): 2.5mg Once daily. Days 1-2 (Tolerance). Community report 1 · Days 3+ (Standard): 5mg Once daily. Days 3+ (Standard). Community report 1 · Alternative BID: 2.5mg Twice daily. 2-4 days. Community report 2 · Days 1-2 (Tolerance): 2.5mg Once daily. Days 1-2 (Tolerance). Community report 2 · Days 3+ (Standard): 5mg Once daily. Days 3+ (Standard). Community report 2 · Alternative BID: 2.5mg Twice daily. 1-2 days. Community report 3 · Days 1-2 (Tolerance): 2.5mg Once daily. Days 1-2 (Tolerance). Community report 3 · Days 3+ (Standard): 5mg Once daily. Days 3+ (Standard). Community report 3 · Alternative BID: 2.5mg Twice daily. Community report 4 · Weeks 1-2 (start low): 50 mg Once daily. Weeks 1-2 (start low). Community report 4 · Weeks 3+ (standard): 100 mg Once daily. Weeks 3+ (standard). Community report 5 · Weeks 3+ (higher end): 150 mg Once daily. Weeks 3+ (higher end).
| Phase | Reported Amount | Frequency | Draw Units | Cycle | Notes | Calculator |
|---|---|---|---|---|---|---|
| Community report 1 · Days 1-2 (Tolerance) | 2.5mg | Once daily | Select a vial | Days 1-2 (Tolerance) | Community-reported protocol. | |
| Community report 1 · Days 3+ (Standard) | 5mg | Once daily | Select a vial | Days 3+ (Standard) | Community-reported protocol. | |
| Community report 1 · Alternative BID | 2.5mg | Twice daily | Select a vial | 2-4 days | Community-reported protocol. | |
| Community report 2 · Days 1-2 (Tolerance) | 2.5mg | Once daily | Select a vial | Days 1-2 (Tolerance) | Community-reported protocol. | |
| Community report 2 · Days 3+ (Standard) | 5mg | Once daily | Select a vial | Days 3+ (Standard) | Community-reported protocol. | |
| Community report 2 · Alternative BID | 2.5mg | Twice daily | Select a vial | 1-2 days | Community-reported protocol. | |
| Community report 3 · Days 1-2 (Tolerance) | 2.5mg | Once daily | Select a vial | Days 1-2 (Tolerance) | Community-reported protocol. | |
| Community report 3 · Days 3+ (Standard) | 5mg | Once daily | Select a vial | Days 3+ (Standard) | Community-reported protocol. | |
| Community report 3 · Alternative BID | 2.5mg | Twice daily | Select a vial | Community-reported protocol. | ||
| Community report 4 · Weeks 1-2 (start low) | 50 mg | Once daily | Select a vial | Weeks 1-2 (start low) | Community-reported protocol. | |
| Community report 4 · Weeks 3+ (standard) | 100 mg | Once daily | Select a vial | Weeks 3+ (standard) | Community-reported protocol. | |
| Community report 5 · Weeks 3+ (higher end) | 150 mg | Once daily | Select a vial | Weeks 3+ (higher end) | Community-reported protocol. |
Dosing Protocol & Schedule
Community-reported research schedules, not clinically validated protocols. Select a reported scenario and duration to calculate mathematical quantities.
| Period | Research Dose | Frequency | Total Injections | Total amount | Volume per entry | U-100 equivalent |
|---|
Strength changes affect volume and supplies, not the underlying community-reported quantities. Figures exceeding the selected syringe capacity are flagged; they are not instructions for splitting administrations.
Plan a Regimen Schedule
Save the selected research protocol to your private calendar. Scheduled entries never create Dose Logs.
Reconstitution Calculator
Select the vial strength you are examining. The reference chart displays examples, not recommended preparation volumes or validated protocols.
Reconstitution Reference Chart
Hypothetical volume comparisons for the selected vial. No particular volume is endorsed, and vial capacity, solubility, excipients and product-specific instructions are not established by this table.
| Example volume | Calculated concentration | Calculator |
|---|---|---|
| 1 mL | — | |
| 2 mL | — | |
| 3 mL | — | |
| 4 mL | — | |
| 5 mL | — |
Choose a compatible dry vial to see reference concentrations.
Research-only mathematical comparisons; not instructions to compound, prepare, or administer peptides. Community-reported protocols are not clinically validated by inclusion here.
Supplies Needed — Estimate
Select a vial strength and an example reconstitution volume below. Counts use only the checked, computable rows above; they are not product-specific sterility, compatibility, or stability guidance.
Select a compatible vial and volume below to view quantities.
Educational and entertainment purposes only. Research use only; not for human or animal administration. Pad counts assume two per Total entry; syringe counts include additional containers where a single entry exceeds the selected syringe capacity. Vial totals assume full theoretical recovery and do not account for dead volume, spoilage, asepsis, expiration, potency, route, or beyond-use dating. These figures are not a recommended supplies list for an actual procedure.
Published References (0 identified)
A recorded identifier identifies a publication; it does not establish that its claims have been independently verified.
Research indexes & other source links
Searches, registries and unverified source records are discovery resources, not verified published studies.
- Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice (2017) View source ↗ Peer-reviewed original research (mouse and cell models) · Publisher or publication identifier recorded; claim verification separate
- PubMed.gov biomedical literature: 5-Amino-1MQ View source ↗ PubMed index/search · Source link recorded; claim verification separate
- ClinicalTrials.gov study registry: 5-Amino-1MQ View source ↗ ClinicalTrials.gov registry/search · Source link recorded; claim verification separate
- NIH/NCBI all-databases search: 5-Amino-1MQ View source ↗ NCBI database/search · Source link recorded; claim verification separate
- PubChem / NIH compound record search: 5-Amino-1MQ View source ↗ PubChem database/search · Source link recorded; claim verification separate
